These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24527714)

  • 1. α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.
    Gottlieb PA; Alkanani AK; Michels AW; Lewis EC; Shapiro L; Dinarello CA; Zipris D
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1418-26. PubMed ID: 24527714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes.
    Alkanani AK; Rewers M; Dong F; Waugh K; Gottlieb PA; Zipris D
    Diabetes; 2012 Oct; 61(10):2525-33. PubMed ID: 22751696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Toll-like receptor signaling pathways in human type 1 diabetes.
    Meyers AJ; Shah RR; Gottlieb PA; Zipris D
    J Mol Med (Berl); 2010 Dec; 88(12):1221-31. PubMed ID: 20725710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat meals induce systemic cytokine release without evidence of endotoxemia-mediated cytokine production from circulating monocytes or myeloid dendritic cells.
    Fogarty CL; Nieminen JK; Peräneva L; Lassenius MI; Ahola AJ; Taskinen MR; Jauhiainen M; Kirveskari J; Pussinen P; Hörkkö S; Mäkinen VP; Gordin D; Forsblom C; Groop PH; Vaarala O; Lehto M
    Acta Diabetol; 2015 Apr; 52(2):315-22. PubMed ID: 25182144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia
    Lebenthal Y; Brener A; Hershkovitz E; Shehadeh N; Shalitin S; Lewis EC; Elias D; Haim A; Barash G; Loewenthal N; Zuckerman-Levin N; Stein M; Tov N; Rachmiel M
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.
    Joosten LA; Crişan TO; Azam T; Cleophas MC; Koenders MI; van de Veerdonk FL; Netea MG; Kim S; Dinarello CA
    Ann Rheum Dis; 2016 Jun; 75(6):1219-27. PubMed ID: 26174021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
    Nita IM; Serapinas D; Janciauskiene SM
    Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
    Weir GC; Ehlers MR; Harris KM; Kanaparthi S; Long A; Phippard D; Weiner LJ; Jepson B; McNamara JG; Koulmanda M; Strom TB;
    Pediatr Diabetes; 2018 Aug; 19(5):945-954. PubMed ID: 29473705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients.
    Thobakgale C; Naidoo K; McKinnon LR; Werner L; Samsunder N; Karim SA; Ndungʼu T; Altfeld M; Naidoo K
    J Acquir Immune Defic Syndr; 2017 Feb; 74(2):213-220. PubMed ID: 27654812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β.
    Agné A; Richter K; Padberg W; Janciauskiene S; Grau V
    Pulm Pharmacol Ther; 2021 Jun; 68():102020. PubMed ID: 33774155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses.
    Pfalzgraff A; Heinbockel L; Su Q; Brandenburg K; Weindl G
    Biochem Pharmacol; 2017 Sep; 140():64-72. PubMed ID: 28539262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus.
    Rachmiel M; Strauss P; Dror N; Benzaquen H; Horesh O; Tov N; Weintrob N; Landau Z; Ben-Ami M; Haim A; Phillip M; Bistritzer T; Lewis EC; Lebenthal Y
    Pediatr Diabetes; 2016 Aug; 17(5):351-9. PubMed ID: 26073583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.
    Lien E; Zipris D
    Curr Mol Med; 2009 Feb; 9(1):52-68. PubMed ID: 19199942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmentally Relevant Level of Aflatoxin B1 Dysregulates Human Dendritic Cells Through Signaling on Key Toll-Like Receptors.
    Mohammadi A; Mehrzad J; Mahmoudi M; Schneider M
    Int J Toxicol; 2014 May; 33(3):175-186. PubMed ID: 24626284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study.
    Agné A; Richter K; Tumpara S; Sauer AL; Beckert F; Wrenger S; Zakrzewicz A; Hecker A; Markmann M; Koch C; Zajonz T; Sander M; Böning A; Padberg W; Janciauskiene S; Grau V
    Int Immunopharmacol; 2020 Apr; 81():106297. PubMed ID: 32062078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.
    Lewis EC; Shapiro L; Bowers OJ; Dinarello CA
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12153-8. PubMed ID: 16093309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.
    Marron TU; Martinez-Gallo M; Yu JE; Cunningham-Rundles C
    J Allergy Clin Immunol; 2012 Jan; 129(1):184-90.e1-4. PubMed ID: 22088613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.
    Domingues R; de Carvalho GC; Aoki V; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 Jun; 14(1):171. PubMed ID: 27286889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.